Skip to content
Contact
Algeria - National academic platform
...

Home › Researcher directory › Peter G. Linde

Peter G. Linde

Affiliation : Acceleron Pharma (United States)

  • 4Publications (affiliation in the United States)
  • 39Total publications
  • 2227Citations
  • 13h-index

Research profile

Peter G. Linde has 4 indexed publications (2018–2020). Their work appears mainly in “Blood” and “New England Journal of Medicine”. Their most cited article, “A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia” (2020), has been cited 332 times. Their work is co-authored with at least 8 researchers, including institutions in Italy, France, Malaysia, Bulgaria.

Is this you? Get your research seen

Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.

Create my free profile Add my publications

Research areas

  • Acute Myeloid Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Hemoglobinopathies and Related Disorders
  • Dialysis and Renal Disease Management
  • Retinoids in leukemia and cellular processes

Publications (4)

Publication venues

  • Blood × 3
  • New England Journal of Medicine × 1

Publications per year

  • 20201
  • 20192
  • 20181

Collaborations

Partner institutions : University of Milan · University of Campania "Luigi Vanvitelli" · Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · Ente Ospedaliero Ospedali Galliera · Azienda Ospedaliera G. Brotzu

Co-authors’ countries : Italy · France · Malaysia · Bulgaria

Co-authors

Bibliographic data from OpenAlex (open database).

Your research deserves to be discovered.

Give my research greater visibility →